Trial
NCT02927938
Leukemia Stem Cell Detection in Acute Myeloid Leukemia
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Wake Forest University Health Sciences
Collaborators
—
Condition
Acute Myeloid Leukemia (AML)
Intervention
Allogeneic HCT
Why stopped
Study terminated 7/23/2019 due to limited participation and testing challenges.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-04-21